IP Library Granted Patent US 11,408,012
Granted Patent B2
US 11,408,012 · App. 17/588,256 · Granted Aug 9, 2022

Nucleic acid-guided nucleases

Inventors: Andrew Garst (Boulder, CO); Ryan T. Gill (Boulder, CO); Tanya Elizabeth Warnecke Lipscomb (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/902C12N9/22C12N15/102C12N15/11C12N15/113C12N15/63C12N15/70C12N15/81C12N15/85C12N15/905C12N15/907C12N2310/20C12N2800/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,408,012
App. No.
17/588,256
Granted
Aug 9, 2022
Kind
B2
Abstract

Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.

Claims (10)

1. A nucleic acid-guided nuclease system comprising: an engineered guide nucleic acid complexed with a nucleic acid-guided nuclease comprising the amino acid sequence of SEQ ID NO: 7 and an editing sequence comprising a nucleic acid sequence complementary to a target region having a change in sequence relative to the target region, wherein the engineered guide nucleic acid comprises the nucleotide sequence of SEQ ID NO: 88, SEQ ID NO: 93, or SEQ ID NO: 94.

2. The nucleic acid-guided nuclease system of claim 1 , wherein the nucleic acid-guided nuclease is encoded by a nucleotide sequence comprising the nucleotide sequence of SEQ ID NO: 27, SEQ ID NO: 47, SEQ ID NO: 133, or SEQ ID NO: 153.

3. The nucleic acid-guided nuclease system of claim 1 , wherein a nucleotide sequence encoding the nucleic acid-guided nuclease is codon optimized.

4. The nucleic acid-guided nuclease system of claim 3 , wherein the nucleotide sequence encoding the nucleic acid-guided nuclease is codon optimized for E. coli.

5. The nucleic acid-guided nuclease system of claim 3 , wherein the nucleotide sequence encoding the nucleic acid-guided nuclease is codon optimized for S. cervisiae.

6. The nucleic acid-guided nuclease system of claim 3 , wherein the nucleotide sequence encoding the nucleic acid-guided nuclease is codon optimized for mammalian cells.

7. The nucleic acid-guided nuclease system of claim 3 , wherein the nucleotide sequence encoding the nucleic acid-guided nuclease is codon optimized for plant cells.

8. The nucleic acid-guided nuclease system of claim 3 , wherein the codon optimized nucleotide sequence encoding the nucleic acid-guided nuclease a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 47, SEQ ID NO: 133, or SEQ ID NO: 153.

9. The nucleic acid-guided nuclease system of claim 1 , wherein an endogenous scaffold sequence comprises the nucleotide sequence of SEQ ID NO: 90.

10. The nucleic acid-guided nuclease system of claim 1 , wherein the engineered guide nucleic acid comprises a pseudoknot region comprising nucleotide residues 17-26 of SEQ ID NO: 200 or nucleotide residues 17-26 of SEQ ID NO: 201.

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Sep 15, 2025
From: INSCRIPTA, INC.,; MANUS INSCRIPTA, INC.
To: MANUS INSCRIPTA, INC.
Reel/Frame 072252/0203 →
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2022
From: GARST, ANDREW; GILL, RYAN T.; WARNECKE LIPSCOMB, TANYA ELIZABETH
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 058902/0731 →
CHANGE OF NAME Recorded Jan 29, 2022
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 058902/0738 →
Continuity (4)
Continuation 16421783 · May 24, 2019
Continuation 15896444 · Feb 14, 2018
Continuation 15632001 · Jun 23, 2017
Related Publication 20220162646A1 · May 26, 2022
Cited By (1)
US 12,195,749